1. Home
  2. GSM vs DNTH Comparison

GSM vs DNTH Comparison

Compare GSM & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.38

Market Cap

594.2M

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

BUY

Current Price

$87.91

Market Cap

5.9B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GSM
DNTH
Founded
2015
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
594.2M
5.9B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
GSM
DNTH
Price
$4.38
$87.91
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
★ $140.80
AVG Volume (30 Days)
★ 1.0M
744.1K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
★ 1.41%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,036,000.00
Revenue This Year
$12.82
N/A
Revenue Next Year
$20.75
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.08
$32.28
52 Week High
$5.74
$117.88

Technical Indicators

Market Signals
Indicator
GSM
DNTH
Relative Strength Index (RSI) 57.82 29.64
Support Level $3.77 $81.16
Resistance Level $4.67 $91.04
Average True Range (ATR) 0.16 4.65
MACD -0.02 -1.03
Stochastic Oscillator 92.04 14.04

Price Performance

Historical Comparison
GSM
DNTH

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's operating segments include Canada - Silicon Metals, Canada - Silicon Alloys, U.S. - Silicon Metals, U.S. - Silicon Alloys, Europe - Manganese Alloys, Europe - Silicon Metals, Europe - Silicon Alloys, South Africa - Silicon Metals, South Africa - Silicon Alloys, and Other segments. The primary raw materials the company uses to produce its electrometallurgy products include its coal and quartz mining operations and its silicon metal and ferroalloy production. The firm generates key revenue from Silicon metal and Manganese-based alloys.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: